Federated Hermes Portfolio holdings
AUM
$53.1B
This Quarter Return
+6.83%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$25.9B
AUM Growth
+$25.9B
(+2.7%)
Cap. Flow
-$658M
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
1,848
New
130
Increased
780
Reduced
759
Closed
101
Top Buys
| 1 |
Southern Company
SO
|
$104M |
| 2 |
Digital Realty Trust
DLR
|
$89.6M |
| 3 |
Philip Morris
PM
|
$72M |
| 4 |
Expro
XPRO
|
$61.1M |
| 5 |
Realty Income
O
|
$51.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$140M |
| 2 |
CIE
Cobalt International Energy, Inc
CIE
|
$105M |
| 3 |
POM
PEPCO HOLDINGS, INC.
POM
|
$101M |
| 4 |
MRC Global
MRC
|
$77.7M |
| 5 |
Gilead Sciences
GILD
|
$73.2M |
Sector Composition
| 1 | Healthcare | 17.46% |
| 2 | Consumer Staples | 11.66% |
| 3 | Energy | 9.4% |
| 4 | Financials | 8.99% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
LyondellBasell Industries
LYB
$17.9B
| $190M | 0.73% |
2,589,276
+128,684
| +5% | +$9.42M |
|
27
Wells Fargo
WFC
$262B
| $184M | 0.71% |
4,443,088
-595,558
| -12% | -$24.6M |
|
|
ESRX
28
DELISTED
Express Scripts Holding Company
ESRX
| $181M | 0.7% |
2,927,876
+222,631
| +8% | +$13.8M |
|
29
National Grid
NGG
$67.9B
| $175M | 0.67% |
2,963,681
-247,492
| -8% | -$14.6M |
|
|
RDS.B
30
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $169M | 0.65% |
2,451,246
+53,627
| +2% | +$3.69M |
|
31
BP
BP
$90.4B
| $166M | 0.64% |
3,954,319
+248,038
| +7% | +$10.4M |
|
32
Eli Lilly
LLY
$659B
| $163M | 0.63% |
3,247,753
+61,926
| +2% | +$3.12M |
|
33
Halliburton
HAL
$19.1B
| $157M | 0.6% |
3,253,217
+39,227
| +1% | +$1.89M |
|
34
GSK
GSK
$79.3B
| $155M | 0.6% |
3,089,410
+57,272
| +2% | +$2.87M |
|
|
CBST
35
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $150M | 0.58% |
2,357,696
-81,304
| -3% | -$5.17M |
|
36
American Electric Power
AEP
$58.6B
| $148M | 0.57% |
3,420,562
+22,988
| +0.7% | +$997K |
|
37
Whirlpool
WHR
$5.08B
| $141M | 0.54% |
962,831
-43,442
| -4% | -$6.36M |
|
38
PepsiCo
PEP
$205B
| $138M | 0.53% |
1,735,733
+6,302
| +0.4% | +$501K |
|
39
Procter & Gamble
PG
$369B
| $136M | 0.53% |
1,803,112
+12,018
| +0.7% | +$908K |
|
|
40
Bristol-Myers Squibb
BMY
$98B
| $128M | 0.49% |
2,755,955
-3,028,164
| -52% | -$140M |
|
|
DYAX
41
DELISTED
DYAX CORPORATION
DYAX
| $127M | 0.49% |
18,529,308
-1,923,814
| -9% | -$13.2M |
|
42
Alkermes
ALKS
$5.08B
| $125M | 0.48% |
3,731,856
-887,280
| -19% | -$29.8M |
|
|
43
Gilead Sciences
GILD
$140B
| $122M | 0.47% |
1,941,217
-1,165,050
| -38% | -$73.2M |
|
|
SLXP
44
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $122M | 0.47% |
1,817,281
-402,819
| -18% | -$26.9M |
|
45
Citigroup
C
$175B
| $114M | 0.44% |
2,340,595
+422,542
| +22% | +$20.5M |
|
46
Hartford Financial Services
HIG
$37.1B
| $108M | 0.42% |
3,466,736
+412,090
| +13% | +$12.8M |
|
47
Biogen
BIIB
$21B
| $105M | 0.4% |
435,891
-31,059
| -7% | -$7.48M |
|
48
Fortune Brands Innovations
FBIN
$6.9B
| $104M | 0.4% |
2,488,944
+210,540
| +9% | +$8.76M |
|
49
CVS Health
CVS
$93.9B
| $99.8M | 0.38% |
1,757,854
-79,155
| -4% | -$4.49M |
|
50
Starbucks
SBUX
$100B
| $94.5M | 0.36% |
1,227,514
+3,288
| +0.3% | +$253K |
|